An Assessment of Laboratory Parameters in Acute Stroke Patients Underwent Decompression Surgery Laboratory Parametersand Decompression
Article Sidebar
Main Article Content
Abstract
Objective: Decompression surgery is applied as a life-saving treatment in patients with malignant cerebral edema. We aimed to evaluate the effect of laboratory parameters such as C-reactive protein and albumin ratio in predicting decompression surgery at an early stage in acute stroke patients.
Material and Method: Demographic characteristics, CRP and albumin values, decompression surgery time, NIHSS and mRS scores of 53 stroke patients who underwent decompression surgery were listed. The patients were grouped according to the time of decompression surgery as 0-24th hours, 24th-48th hours, 48th-72th hour and after 72th hours and the laboratory parameters of each group were evaluated.
Results: The mean age of 31 male and 22 female patients was 61±14 (34-91) years. There was no significant difference between the groups in terms of gender, NIHSS, and mRS scores. A statistically significant difference was detected between the first and second groups (p=0.024) when comparing the CRP and albumin ratios.
Conclusion: Markers of inflammation, serum CRP, and albumin ratios were evaluated to determine their usefulness in suggesting the timing of surgical treatment. It was observed that a high CRP and albumin ratio at the time of admission could serve as a predictive factor for surgery within the first 24 hours. Our findings suggest that patients with a high CRP albumin ratio may require surgical treatment within the first 24 hours.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2023-06-19
Published 2023-06-19
References
Kolias AG, Kirkpatrick PJ, Hutchinson PJ. Decompressive craniectomy: past, present and future. Nat Rev Neurol. 2013;9:405–15. doi: 10.1038/nrneurol.2013.106
Fung C, Murek M, Z’Graggen WJ, et al. Decompressive Hemicraniectomy in Patients with Supratentorial Intracerebral Hemorrhage. Stroke. 2012;43:3207-3211
Thijs LG, Hack CE. Time course of cytokine levels in sepsis. Intensive Care Med. 1995;21:S258–S263.
Ho KM, Lee KY, Dobb GJ, Webb SA. C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: A prospective cohort study. Intensive Care Med. 2008;34:481–487.
Ho KM, Dobb GJ, Lee KY, Towler SC, Webb SA. C-reactive protein concentration as a predictor of intensive care unit readmission: A nested case-control study. J Crit Care. 2006;21:259–265.
Villacorta H, Masetto AC, Mesquita ET. C-reactive protein: An inflammatory marker with prognostic value in patients with decompensated heart failure. Arq Bras Cardiol. 2007;88:585–589.
Devran O, Karakurt Z, Adiguzel N, Gungor G, Mocin OY, Balci MK, Celik E, Salturk C, Takir HB, Kargin F, et al. C-reactive protein as a predictor of mortality in patients affected with severe sepsis in intensive care unit. Multidiscip Respir Med. 2012;7:47–53.
Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C, Vincent JL. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003;123:2043–2049.
Hacke W, Schwab S, Horn M, Spranger M, de Georgia M, von Kummer R. 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol. 1996;53:309–15.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics−2014 update: a report from the American Heart Association. Circulation. 2014;129:e28–92.
Berrouschot J, Sterker M, Bettin S, Köster J, Schneider D. Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care. Intensive Care Med. 1998;24:620–3.
Kasner SE, Demchuk AM, Berrouschot J, Schmutzhard E, Harms L, Verro P, et al. Predictors of fatal brain edema in massive hemispheric ischemic stroke. Stroke. 2001;32:2117–23.
Anrather J, Iadecola C. Inflammation and Stroke: An Overview. Neurotherapeutics. 2016 Oct;13(4):661-670. doi: 10.1007/s13311-016-0483-x. PMID: 27730544; PMCID: PMC5081118.
Gupta R, Connolly ES, Mayer S, Elkind MS. Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. Stroke. 2004;35:539.
Hofmeijer J, Kappelle LJ, Algra A, Amelink GJ, van Gijn J, van der Worp HB; HAMLET investigators. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomized trial. Lancet Neurol. 2009 Apr;8(4):326-33.
Jüttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J, Witte S, Jenetzky E, Hacke W; DESTINY Study Group. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke. 2007 Sep;38(9):2518-25. doi: 10.1161/STROKEAHA.107.485649. Epub 2007 Aug 9. PMID: 17690310.
Vahedi K, Vicaut E, Mateo J, Kurtz A, Orabi M, Guichard JP, Boutron C, Couvreur G, Rouanet F, Touzé E, Guillon B, Carpentier A, Yelnik A, George B, Payen D, Bousser MG; DECIMAL Investigators. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007 Sep;38(9):2506-17. doi: 10.1161/STROKEAHA.107.485235. Epub 2007 Aug 9. PMID: 17690311.